Les publications scientifiques permettent de partager nos découvertes avec nos collègues du monde entier.
Avec plus de 150 publications depuis sa création, l’IRHT connaît un rayonnement international.
Quelques-unes de nos dernières publications :
- Industrialized GMP Production of CD34+ Cells (ProtheraCytes®) at Clinical Scale for Treatment of Ischemic Cardiac Diseases Is Feasible and Safe
Hénon P, Kowalczyk M, Aries A, Vignon C, Trébuchet G, Lahlil RStem Cell Reviews and Reports 2022, https://doi.org/10.1007/s12015-022-10373-5. Cliquer pour accéder au site de l’éditeur ou l’article complet en pdf (Anglais)
- CD34+ Stem Cells and Regenerative Medicine Henon P, Lahlil R. Stem Cells Cliquer pour télécharger
- Purification of CD34+ Stem Cells from Myelodysplastic Syndrome with Ring Sideroblasts using Immunomagnetic Strategy.
Barbet R, Eidenschenk A, Harzallah I, Hénon P, Drénou B.
Biomedical Journal of Scientific & Technical Research March, 2021, Volume 34, 5, pp 27062-27069. Lire le résumé (Français), Accéder au site de l’éditeur ou l’article complet en pdf - Differential Expression of the Tetraspanin CD9 in Normal and Leukemic Stem Cells.
Lahlil R, Scrofani M, Aries A, Hénon P, Drénou B.
Biology 2021, 10, 312. https://doi.org/10.3390/ biology10040312. Cliquer pour lire le résumé ou l’article complet en pdf (Anglais) - Fibrous biomaterials : Effect of textile topography on foreign body reaction.
Girault E, Biguenet F, Eidenschenk A, Dupuis D, Barbet R, Heim F.
J Biomed Mater Res B Appl Biomater. 2021 Feb 1. doi : 10.1002/jbm.b.34810. Cliquer pour lire le résumé (Anglais) ou en Français sur notre page actualité - CD34+ Very Small Embryonic-Like Stem Cells or Induced Pluripotent Stem Cells for Cardiac Repair.
Henon P, Lahlil R and Aries A.
Journal of Cardiology and Vascular Medicine. 2020 ; 6 : 1-12. Cliquer pour Télécharger - Design and Validation of an Automated Process for the Expansion of Peripheral Blood-Derived CD34 + Cells for Clinical Use After Myocardial Infarction. Saucourt C, Vogt S, Merlin A, Valat C, Criquet A, Harmand L, Birebent B, Rouard H, Himmelspach C, Jeandidier E, Chartois-Leauté A-G, Derenne S, Koehl L, Salem J-E, Hulot J-S, Tancredi C, Aries A, Judé S, Martel E, Richard S, Douay L, Hénon P. Stem Cells Transl Med. 2019 Aug;8(8):822-832. doi : 10.1002/sctm.17-0277. Epub 2019 Apr 29. Cliquer pour Télécharger
- VSELs Maintain their Pluripotency and Competence to Differentiate after Enhanced Ex Vivo Expansion Lahlil R, Scrofani M, Barbet R, Tancredi C, Aries A, Hénon P. Published : 08 May 2018 Cliquer pour Télécharger
- Human Very Small Embryonic-Like Stem Cells Are Present in Normal Peripheral Blood of Young, Middle-Aged, and Aged Subjects.
Sovalat H, Scrofani M, Eidenschenk A, Hénon P.
Stem Cells Int. 2016 ; 2016:7651645. - Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy.
Schmitt C, Voegelin M, Marin A, Schmitt M, Schegg F, Hénon P, Guenot D, Tarnus C.
Bioorg Med Chem. 2013 Apr 1 ; 21(7):2135-44. - Identification and isolation from either adult human bone marrow or G-CSF-mobilized peripheral blood of CD34(+)/CD133(+)/CXCR4(+)/ Lin(-)CD45(-) cells, featuring morphological, molecular, and phenotypic characteristics of very small embryonic-like (VSEL) stem cells.
Sovalat H, Scrofani M, Eidenschenk A, Pasquet S, Rimelen V, Hénon P.
Exp Hematol. 2011 Apr ; 39(4):495-505. - Three-dimensional distribution patterns of CD34 antigen on nonactivated cord blood cells.
Jung G, Wunder E, Dieterlen A, Hénon P, Jacquey S.
Cytometry A. 2008 Jan ; 73(1):16-21. - Long-term benefit of intracardiac delivery of autologous granulocyte-colony-stimulating factor-mobilized blood CD34+ cells containing cardiac progenitors on regional heart structure and function after myocardial infarct.
Pasquet S, Sovalat H, Hénon P, Bischoff N, Arkam Y, Ojeda-Uribe M, Bouar Rl, Rimelen V, Brink I, Dallemand R, Monassier JP.
Cytotherapy. 2009;11(8):1002-15. - Relative quantification of residual tumor cells by lightcycler real-time IgH PCR in autografted multiple myeloma patients.
Rimelen V, Ferrand C, Debecker A, Sovalat H, Tancredi C, Eidenschenk A, Hénon P.
Leukemia. 2005 Mar ; 19(3):492-5. - Peripheral blood and BM CD34+ CD38- cells show better resistance to cryopreservation than CD34+ CD38+ cells in autologous stem cell transplantation.
Ojeda-Uribe M, Sovalat H, Bourderont D, Brunot A, Marr A, Lewandowski H, Chabouté V, Peter P, Henon P.
Cytotherapy. 2004;6(6):571-83. - CD34+ cells and CD34+CD38- subset from mobilized blood show different patterns of adhesion molecules compared to those from steady-state blood, bone marrow, and cord blood.
Sovalat H, Racadot E, Ojeda M, Lewandowski H, Chabouté V, Hénon P.
J Hematother Stem Cell Res. 2003 Oct;12(5):473-89. - Importance of CD34+ cell subsets in autologous PBSC transplantation : the mulhouse experience using CD34+CD38- cells as predictive tool for hematopoietic engraftment.
Hénon PH, Sovalat H, Bourderont D.
J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):62-7. Review. - Human accessory cells have a humoral bystander effect on CAFC growing on murine feeder.
Mazini L, Wunder E, Sovalat H, Jung G, Bourderont D, Bachorz J, Bearenzung M, Zanetti C, Hénon P.
J Hematother Stem Cell Res. 2000 Oct;9(5):749-57.
